Public Sector Pension Investment Board Has $3.50 Million Holdings in Cardiovascular Systems, Inc. (NASDAQ:CSII)

Public Sector Pension Investment Board reduced its holdings in Cardiovascular Systems, Inc. (NASDAQ:CSII) by 0.8% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 82,070 shares of the medical device company’s stock after selling 660 shares during the quarter. Public Sector Pension Investment Board owned approximately 0.20% of Cardiovascular Systems worth $3,500,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Versant Capital Management Inc boosted its holdings in shares of Cardiovascular Systems by 32.9% in the 2nd quarter. Versant Capital Management Inc now owns 1,353 shares of the medical device company’s stock worth $58,000 after acquiring an additional 335 shares in the last quarter. Mutual of America Capital Management LLC lifted its holdings in Cardiovascular Systems by 6.4% during the 2nd quarter. Mutual of America Capital Management LLC now owns 5,710 shares of the medical device company’s stock worth $244,000 after buying an additional 342 shares in the last quarter. State of Alaska Department of Revenue lifted its holdings in Cardiovascular Systems by 2.2% during the 2nd quarter. State of Alaska Department of Revenue now owns 27,787 shares of the medical device company’s stock worth $1,185,000 after buying an additional 585 shares in the last quarter. Great Lakes Advisors LLC lifted its holdings in Cardiovascular Systems by 7.0% during the 2nd quarter. Great Lakes Advisors LLC now owns 9,284 shares of the medical device company’s stock worth $396,000 after buying an additional 606 shares in the last quarter. Finally, State Board of Administration of Florida Retirement System lifted its holdings in Cardiovascular Systems by 3.9% during the 2nd quarter. State Board of Administration of Florida Retirement System now owns 21,099 shares of the medical device company’s stock worth $900,000 after buying an additional 797 shares in the last quarter. 94.30% of the stock is currently owned by institutional investors and hedge funds.

Shares of Cardiovascular Systems stock opened at $32.12 on Thursday. The firm has a fifty day moving average of $35.18 and a two-hundred day moving average of $37.86. The stock has a market capitalization of $1.30 billion, a price-to-earnings ratio of -94.47 and a beta of 0.86. Cardiovascular Systems, Inc. has a 52 week low of $31.20 and a 52 week high of $48.28. The company has a debt-to-equity ratio of 0.08, a quick ratio of 4.62 and a current ratio of 5.21.

Cardiovascular Systems (NASDAQ:CSII) last issued its earnings results on Wednesday, August 4th. The medical device company reported ($0.14) EPS for the quarter, beating the consensus estimate of ($0.17) by $0.03. The company had revenue of $70.99 million during the quarter, compared to analysts’ expectations of $69.00 million. Cardiovascular Systems had a negative net margin of 5.18% and a negative return on equity of 4.95%. The business’s revenue was up 66.8% compared to the same quarter last year. As a group, research analysts forecast that Cardiovascular Systems, Inc. will post -0.2 EPS for the current fiscal year.

Several research analysts have issued reports on the company. SVB Leerink reaffirmed a “buy” rating on shares of Cardiovascular Systems in a report on Sunday, September 26th. Northland Securities reaffirmed a “buy” rating and set a $45.00 price objective on shares of Cardiovascular Systems in a report on Friday, July 16th. Finally, Needham & Company LLC reduced their price objective on Cardiovascular Systems from $50.00 to $49.00 and set a “buy” rating on the stock in a report on Thursday, September 23rd. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus price target of $44.75.

Cardiovascular Systems Company Profile

Cardiovascular Systems, Inc is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St.

Featured Article: Equal Weight Rating

Want to see what other hedge funds are holding CSII? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardiovascular Systems, Inc. (NASDAQ:CSII).

Institutional Ownership by Quarter for Cardiovascular Systems (NASDAQ:CSII)

Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.